Observational studies did not find a significant difference in lupus risk between GLP-1 receptor agonist users and non-users
Studies show that while GHRP-2 and GHRP-6 administration resulted in increased plasma levels of ACTH and cortisol, ipamorelin did not release ACTH or cortisol at levels significantly different from those observed following growth hormone-releasing hormone (GHRH) stimulation
J., Huang, Y., Lambros, M., Gout, P
1000 , 500 - 25
If youre using a GLP-1 medication for weight loss, we recommend a few key lifestyle adjustments to maximize your results and improve your overall health
It helps you make informed decisions about your health, manage potential risks, and recognize when something might be wrong